CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 250641-250803 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T1945","span":{"begin":0,"end":162},"obj":"Sentence"},{"id":"T82663","span":{"begin":0,"end":162},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Doripenem's superior stability allowed the VAP trial to utilise an extended infusion (4-h) regimen for doripenem that may maximise for these difficult infections."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T44","span":{"begin":0,"end":162},"obj":"Sentence"}],"text":"Doripenem's superior stability allowed the VAP trial to utilise an extended infusion (4-h) regimen for doripenem that may maximise for these difficult infections."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T548","span":{"begin":0,"end":162},"obj":"Epistemic_statement"}],"text":"Doripenem's superior stability allowed the VAP trial to utilise an extended infusion (4-h) regimen for doripenem that may maximise for these difficult infections."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T904","span":{"begin":151,"end":161},"obj":"Disease"},{"id":"T65960","span":{"begin":151,"end":161},"obj":"Disease"}],"attributes":[{"id":"A904","pred":"mondo_id","subj":"T904","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A83146","pred":"mondo_id","subj":"T65960","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Doripenem's superior stability allowed the VAP trial to utilise an extended infusion (4-h) regimen for doripenem that may maximise for these difficult infections."}